Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Brain Radiation-Induced Fatigue
NCT01032200Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fatigue comparing Armodafinil with Placebo (2 arms). Primary endpoints: Retention Rate and Adherence Rate. Started Aug 2010; status: completed.
02
Drugs
armodafinil
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT01032200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032200.